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ABSTRACT
Nuclear speckles are known to be the storage sites
of mRNA splicing regulators. We report here
the identification and characterization of a novel
speckle protein, referred to as NSrp70, based on
its subcellular localization and apparent molecular
weight. This protein was first identified as CCDC55
by the National Institutes of Health Mammalian
Gene Collection, although its function has not
been assigned. NSrp70 was colocalized and physic-
ally interacted with SC35 and ASF/SF2 in speckles.
NSrp70 has a putative RNA recognition motif, the
RS-like region, and two coiled-coil domains,
suggesting a role in RNA processing. Accordingly,
using CD44, Tra2b1 and Fas constructs as splicing
reporter minigenes, we found that NSrp70
modulated alternative splice site selection in vivo.
The C-terminal 10 amino acids (531–540), including
536RD
537, were identified as a novel nuclear localiza-
tion signal, and the region spanning 290–471 amino
acids was critical for speckle localization and
binding to SC35 and ASF/SF2. The N-terminal
region (107–161) was essential for the pre-mRNA
splicing activity. Finally, we found that knockout of
NSrp70 gene in mice led to a lack of progeny,
including fetal embryos. Collectively, we demon-
strate that NSrp70 is a novel splicing regulator
and essentially required early stage of embryonic
development.
INTRODUCTION
Nuclear speckles are subnuclear structures that appear as
irregular, punctuate structures which vary in size and
shape when analyzed under a ﬂuorescence microscope.
They are located in the interchromatin regions of the
nucleoplasm of mammalian cells. These particles occur
in localized ‘clouds’, and cytochemical analysis indicates
that they contain RNA (1). Using antibodies speciﬁc to
splicing factors such as small nuclear ribonucleoprotein
particles (snRNPs), the connection between nuclear
speckles and pre-mRNA splicing was initially determined
(2). It is now clear that nuclear speckles serve as storage
sites of the components of the pre-mRNA splicing
machinery, including snRNPs, spliceosome subunits and
other non-snRNP protein splicing factors, and therefore
play an important role in alternative splicing.
Alternative pre-mRNA splicing is a critical step in gene
expression and proteomic diversity in all metazoans.
Puriﬁcation and analysis of the multiple proteins in
speckles show that these can be roughly separated into
two classes: one class consists of relatively widely
expressed proteins, which seem to have wide-ranging
roles in mRNA biogenesis. These proteins can be classiﬁed
into two groups: SR proteins and hnRNP proteins. SR
proteins tend to promote exon inclusion while hnRNP
proteins usually have the opposite effect (3). The other
class consists of factors with restricted expression
patterns that are responsible for regulating tissue-speciﬁc
alternative splicing events. These proteins, including
Nova-1/2 and Hu proteins, have been identiﬁed by a
variety of approaches and each of them shares a salient
feature: each contains an RNA-binding domain of the K
homology or RNA recognition motif (RRM) type (3).
Members of the SR family include ASF/SF2, SC35 and
SRp20. Each of these proteins is required for constitutive
splicing and can regulate alternative splicing. SR proteins
are essential splicing factors since they can complement
splicing-deﬁcient S100 extracts (4). They contain one or
more RRMs and a C-terminal arginine/serine (RS)-rich
domain that contains serine residues that can be
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binding to the RNA, whereas the RS-rich domain is
mainly involved in protein–protein interactions that are
thought to be essential for the recruitment of the
splicing machinery, for splice-site pairing (7,8), and for
nuclear localization signaling (NLS) to the speckles (9).
Notably, deletion of two SR proteins, ASF/SF2 or
SC35, in the germ line of mice leads to embryonic lethality
before day 7.5 (10–13).
Another class of splicing factors is SR-related proteins,
which contain RS domains of varying lengths. Unlike SR
proteins, SR-related proteins may or may not contain a
RRM, and instead may contain other domains such as a
DEXD/H box or a zinc ﬁnger. U2AF35, U1-70K and
SRm160 are all examples of SR-related proteins (14),
and many other proteins have recently been shown to
belong to this family.
Recently, we unexpectedly found, through microarray
analysis, a gene that can potentially affect T-cell motility.
This gene was ﬁrst identiﬁed and named as coiled-coil
domain containing 55 (CCDC55) by the National
Institutes of Health Mammalian Gene Collection
program because it contains a coiled-coil domain in its
sequence. This gene was signiﬁcantly up-regulated in
motile cells, but down-regulated in non-motile cells.
However, both ectopic expression and knockdown experi-
ments revealed no speciﬁc connection of CCDC55 protein
with T-cell motility. As identiﬁcation of CCDC55 in the
nuclear speckle domain provided us with new insights into
the splicing machinery (15), we compared the sequence of
CCDC55 with other known splicing-related proteins.
Interestingly, we found that CCDC55 had putative
RRMs in the N terminus, an RS-like region in the C
terminus, and two coiled-coil domains in both the N-
and C-termini, thereby suggesting a role in RNA process-
ing. Thus, based on its subcellular localization and mo-
lecular weight on SDS–PAGE, we renamed this protein as
nuclear speckle-related protein 70 (NSrp70) and further
explored its biological functions. We found that NSrp70
interacted and colocalized with SC35 and ASF/SF2 in
nuclear speckles and modulated alternative splice site se-
lection in vivo as determined by CD44, Tra2b1 and Fas
minigenes. We determined the regions for the NLS
sequence, for speckle localization and binding to SC35
and ASF/SF2, and for the pre-mRNA splicing activity.
Finally, based on the NSrp70 knockout mice approach,




Phorbol 12-myristate 13-acetate (PMA), A23187, ﬂuores-
cein isothiocyanate (FITC)-conjugated anti-rabbit IgG,
phalloidin-TRITC, and rabbit polyclonal anti-human
NSrp70 (CCDC55) antibody were purchased from Sigma
Chemical Co. (St. Louis, MO). 40, 6-diamidino-
2-phenylindole dihydrochloride (DAPI) was purchased
from Molecular Probes (Eugene, OR). DirectPCR Lysis
Reagent (Tail) was purchased from VIAGEN Biotech
(Wilshire Boulevard, LA, USA). Recombinant Human
SDF-1a was purchased from R&D Systems
(Minneapolis, MN, USA). Welprep
TM Total RNA
Isolation Reagent was purchased from JBI (Join Bio
Innovation, Korea). Reverse transcript PCR premix and
conventional PCR premix were purchased from iNtRON
(iNtRON Biotechnology, Korea). Magna RIP
TM Kit was
purchased from Millipore (Billerica, MA, USA). Goat
polyclonal anti-human b-actin, mouse monoclonal
anti-myc-tag (9B11), rabbit polyclonal anti-human acetyl-
histone H2A (Lys5) and rabbit polycolonal anti-human
PARP antibodies were purchased from Cell Signaling
Technology (Beverly, MA, USA). Rabbit polyclonal anti-
human I-kB antibody was purchased from Santa Cruz bio-
technology (Santa Cruz, CA, USA). Mouse and rabbit
polyclonal anti-human SC35 antibody was purchased
from BD Pharmingen (San Jose, CA, USA). Rabbit
polyclonal anti-GFP antibody was developed in rabbit
using puriﬁed recombinant full-length GFP protein.
[a-
32P]dCTP was purchased from Perkin Elmer
(Waltham, MA, USA). OmicsLink
TM shRNA expression
clone and siRNA against NSrp70 were purchased from
GeneCopoeia
TM (Germantown, MD, USA) and
Dharmacon Inc. (Chicago, IL, USA), respectively.
Cell cultures and transfections
COS-7 and HEK293T cells were maintained in DMEM
(Gibco-BRL, Gaithersburg, MD, USA) supplemented
with 10% FBS (Giboco-BRL), penicillin and streptomycin
(100mg/ml; Invitrogen, Carlsbad, CA, USA). Constructs
were transfected by Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA) in HEK293T or COS-7 cells accord-
ing to the manufacturer’s instructions. At 24h after trans-
fection, cells were collected for RNA puriﬁcation or
biochemical analysis. Transfection in Jurkat T cells was
performed by Nucleofector Kit V (Amaxa, Koeln,
Germany) according to the manufacturer’s instructions.
Plasmids
The mammalian expression vector of pEGFP-C1/ASF/
SF2 and pETv5/CD44, and pCR3.1/MGTra minigene
were generous gifts from Dr Brain J. Morris (University
of Sydney, NSW2006, Australia). Fas minigene was a gift
from Dr Michael Sattler (GSF-National Research Center
for Environment and Health, Neuherberg, Germany). The
pEGFP-C3/SP100, Daxx and PML3 were obtained from
Dr David J. Picketts (University of Pennsylvania School
of Medicine, Philadelphia, PA, USA). The cDNA of SC35
was obtained by RT–PCR using total RNA prepared
from Jurkat T cells as a template. These cDNAs were
then inserted into pCS4-3Myc, pEGFP-C1 and
pmCherry-C1 by in-frame fusion. To generate the
pEGFP/NSrp70 construct, the human NSrp70 clone
coding the full-length open reading frame of NSrp70
(CCDC55) was purchased from imaGenes ORF
Expression Clone (imaGenes GmbH, Germany). DNA
fragments encoding NSrp70 or deletion or substitution
mutants were generated by PCR from full-length
NSrp70 ORF clone and inserted into pEGFP-C1 or
pmCherry-C1. The expression vectors for chimeric
Nucleic Acids Research, 2011,Vol.39, No. 10 4301NSrp70 proteins were as follows: M16 (290C_fNLS),
which is 1–289 amino acid of NSrp70 in-frame fused
with NLS of NUCKS (nuclear casein kinase and
cyclin-dependent kinase substrate); M17 ( 105N_
290C_fNLS), which is 106–289 amino acids of NSrp70
in-frame fused with NLS of NUCKS. All the NSrp70
deletion mutants, chimeric muatants and SR proteins con-
tained in-frame tagged GFP, mCherry or Myc at the
N-terminus, and their sequences were veriﬁed by automat-
ic sequencing.
Immunoﬂuorescence staining and confocal imaging
analysis
For visualization of ﬂuorescence, cells were cultured on
18-mm non-coated round coverslips (Nalge Nunc
International, Denmark) and ﬁxed with 3.7% formalde-
hyde for 15min. After blocking with either 5% BSA in
phosphate-buffered saline (PBS) for 1h, the primary
antibodies were applied for overnight at 4 C, followed
by the secondary antibodies for 1h. In some case, cells
were stained with 300nM 40, 6-diamidino-2-phenylindole
dihydrochloride (DAPI) (Molecular Probes, Eugene, OR,
USA) before being mounted with gelatine/glycerol in PBS,
50:50 vol./vol. (Sigma Chemical Co., St Louis, MO,
USA). The samples were examined with a FV1000
confocal laser scanning microscope (Olympus, Japan)
equipped with 40 ,6 0   and 100  objectives. For the
live-cell imaging, cells were directly mounted in a
PC-R-10 bath ﬂow chamber (Live Cell Instruments,
Seoul, Korea) and observed by FV1000 confocal
microscopy.
Immunoprecipitation and western blotting
Cell extracts from HEK293T or COS-7 cells (1 10
7 cells)
which were transfected with indicated constructs were
prepared by lysis buffer (1% Triton X-100, 150mM
NaCl, 20mM Tris pH 7.5). Approximately 1mg of the
extract was mixed with 50ml of pre-anti-GFP or anti-
NSrp70 antibody-conjugated Sepharose 4B (GE
Healthcare, Sweden). The immunocomplexes were
incubated overnight at 4 C with frequent mixing,
washed two times with washing buffer I (1% Triton
X-100, 150mM NaCl, 20mM Tris–HCl pH 7.5) and
buffer II (150mM NaCl, 10mM Tris–HCl pH 7.5) for
each and resolved by 12% SDS–PAGE. Proteins were
electroblotted on to a PVDF membrane (Perkin Elmer)
by means of a Trans-Blot SD semidry transfer cell
(Bio-Rad, Hercules, CA, USA). The membrane was
blocked in 5% skim milk (1h), rinsed, and incubated
with the indicated antibodies in TBS containing 0.1%
Tween-20 (TBS-T) and 3% skim milk overnight. Excess
primary antibody was removed by washing the membrane
four times in TBS-T. The membrane was then incubated
with 0.1mg/ml peroxidase-labeled secondary antibody
(against rabbit or mouse) for 2h. After three washes in
TBS-T, bands were visualized by ECL western blotting
detection (iNtRON Biotechnology Inc.). RNA immuno-
precipitation experiments were performed according to the
protocol provided by the kit (Millipore; catalog 17–701).
Nuclear fractionation
HEK293T or COS-7 cells (1 10
7 cells) were washed in
ice-cold PBS and resuspended in 1ml of hypotonic
digitonin extraction buffer (5mM Tris pH 7.5, 10mM
NaCl, 0.5mM MgCl2, 1mM EGTA, 1mM DTT, 40mg/
ml digitonin, 5mg/ml aprotinin, 10mg/ml leupeptin, 1mM
PMSF and 1mM Na3VO4). After 15min on ice, the cells
were pelleted for 5min at 1000g, and the suspernatant was
collected and assayed for cytosol protein content. The in-
soluble pellet was washed with PBS, and then re-extracted
with 0.5ml of NP-40 lysis buffer (10mg/ml Tris pH 7.5,
40mM NaCl, 1mM MgCl2, 1mM DTT, 0.2% NP-40,
5mg/ml aprotinin, 10mg/ml leupeptin, 1mM PMSF and
1mMNa 3VO4). The samples were vortexed and incubated
on ice for 10min. Cell lysates were cleared of insoluble
material by centrifugation at 18000g and soluble
proteins were quantitated. Aliquots of the digitonin- and
NP-40-extractable fractions from each sample were
resolved by SDS–PAGE and analyzed by western blot.
In vivo splicing assays
In vivo splicing assays were performed essentially as
described (16,17). Brieﬂy, a splicing reporter minigene
was co-transfected with an increasing amount of NSrp70
expression construct (pEGFP/NSrp70) in HEK293T cells.
Empty pEGFP-C1 plasmids were added to ensure that the
same amount of DNA was transfected. After 24h of trans-
fection, RNA was isolated using Welprep
TM Total RNA
Isolation Reagent. RT–PCR for the CD44 minigene was
performed using primers N3INS (50-CTCCCGGGCCAC
CTCCAGTGCC-30) and N5INS (50-GAGGGATCCGCT
TCCTGCCCC-30) and a program involving 30 cycles of
94 C for 20 s, 68 C for 30 s and 72 C for 40 s. For Tra2b1,
we used primer pCR3.1-RT-Rev (50-GCCCTCTAGACT
CGAGCTCGA-30) for the RT and primers MGTra-Bam
(50-GGGCCAGTTGGGCGACCGGCGCGTCGTGCG
CGGGG-30) and MGTra-R-Xho (50-GGGCTCGAGTA
CCCGATTCCCAACATGACG-30) for the PCR consist-
ing of 35 cycles of 94 C for 20 s, 65 C for 20 s and 72 C
for 40 s. For Fas, we used primers PT1 (50-GTCGACGAC
ACTTGCTCAAC-30) and PT2 (50-AAGCTTGCATCGA
ATCAGTAG-30) for the PCR consisting of 33 cycles of
94 C for 20 s, 60 C for 10 s and 72 C for 20 s. The PCR
products were analyzed with a 1% agarose gel and the
splicing pattern was quantiﬁed using ImageJ 1.44d
(ImageJ is a public domain Java image processing
program inspired by National Institutes of Health Image).
Knockout mouse
To obtain knockout mice, we searched Gene-Trap embry-
onic stem (ES) cell repositories for NSrp70 (CCDC55)
insertions. A BLAST search using the mouse cDNA
sequence identiﬁed line Ayu21-T93. C57B6 NSrp70
+/GT
heterozygous mouse was generated as follows. Brieﬂy, ex-
changeable gene trap pU-21T vector was used for random
gene trap mutagenesis. The mutant construct contains a
splice acceptor sequence linked to the b-geo reporter gene,
and its integration site is concentrated in the 50-end of a
trapped gene. pU-21T (20–40mg) was transfected by
4302 Nucleic Acids Research, 2011,Vol.39, No. 10electroporation (800 V, 3mF with Bio-Rad Gene Pulser)
into the feeder-free ES cell line KTPU8 (F1 of B6 and
CBA). Thereafter, G418-resistant clones were selected
and expanded. Genomic DNA were prepared from
clones and examined by PCR and Southern blotting for
single-copy integration and for the existence of lox71–
lox2272 sites, which are indispensable for site-speciﬁc re-
combination. To identify the trapped gene, 50-RACE was
performed. We found that pU-21T was inserted at 1141bp
downstream of the exon 1 of NSrp70 gene. Furthermore,
we found that the 50-end 569bp of trap vector was deleted.
Clones that had trap gene insertion in NSrp70 were used
to generate chimeric mice. ES cells were aggregated with
morulae from ICR (Imprinting Control Region) mice. We
used 125 morulae per line and transferred them into ﬁve
foster mothers. Chimeric mice were mated with C57BL/6
females. Genomic DNAs of F1 progenies and original ES
cells were subjected to Southern blotting to conﬁrm that
the integration pattern of the vector is identical between
the mouse line and the original ES clone.
PCR genotyping assay of embryos and progenies
Tails of embryos or progenies were lysed in 1.5ml tubes
containing tail lysis buffer (DirectPCR Lysis Reagent,
VIAGEN Biotech), and 2mg lysate was used in for PCR
genotyping. The PCR primers for the wild-type allele
were located in exon 1 (21T 93-1: 50-ATATACACGTC
GGCGTCAGC-30) and exon-2 (21T93-3R: 50-CAAAAT
AAGCCCATACCTGCGTAA-30), and the PCR primers
for the trap allele were located between exon 1 and exon
2 (21T93-9: 50-GAAGAGAGGCCCATTGGTTG-30,
SA-5AS: 50-GGGCAAGAACATAAAGTGACC-30).
Primers 21T93-1 and 21T93-3R were used in PCR of
1737 base pairs of nature intron 1 (35 cycles of 1min at
94 C, 1min at 58 C, and 2min at 72 C), and primers
21T93-9 and SA-5AS were used in PCR of 597 base
pairs that consist of the partial trap vector and the
intron 1 sequence (35 cycles of 1min at 94 C, 15 s at
56 C, and 30 s at 72 C).
Lenti-viral infection
Lenti-viral vector (2mg of non-target psiLv-H1 or NSrp70
target psiLv-H1) with the appropriate insert (10mg
of packaging plasmid) was transfected into HEK293T
cells using lipofectamine 2000 (Invitrogen). The culture
supernatants were collected 48h after transfection. The
supernatants were pooled, concentrated by ultracentri-
fugation, and stored at  80 C until use. For lenti-viral
infection, virus particles were mixed with Jurkat T cells
(2 10
5/500ml) in a 15-ml centrifuge tube in the pres-
ence of 8mg/ml polybrene. Following centrifugation at
1341g for 1h, the cells were transferred into a 60-mm
culture dish and infection and knockout efﬁciency were
checked after 48h of infection by FACs analysis and
RT–PCR.
Cell migration assay
Cell migration assay was performed using transwell
chemotaxis system (CHEMOTX system, 3–5mm pores,
Neuro Probe Inc., Gaithersburg, MD, USA).
Lymphocytes (5 10
5) obtained from wild-type or
NSrp70
+/GT were placed on the upper wells (50ml), and
media containing 50ng/ml SDF-1a were added to the
lower wells (30ml). The plates were incubated for 2.5h at
37 C in a humidiﬁed CO2 incubator. After incubation, the
inserts were removed, and the cells that had migrated
through the ﬁlter to the lower wells were counted
by using ImageJ 1.44d. Three different ﬁelds for each
well were selected for imaging and the cells within the
microscope ﬁeld were counted using ImageJ 1.44d.
RESULTS
NSrp70 is a novel nuclear speckle protein
In this study, we initially identiﬁed NSrp70 as a
migration-related gene in T cells. As shown in
Supplementary Figure S1A, the expression of NSrp70
was  4-fold higher in motile T cells than in parent
T cells. In silico analysis based on BioGPS showed that
NSrp70 is highly expressed in immune function-related
cells, including dendritic cells, T cells, B cells and
natural killer cells (Supplementary Figure S1B).
Northern blot analysis consistently revealed that NSrp70
is signiﬁcantly expressed in secondary lymphoid organs
such as spleen; and mesenteric, axillary and brachial
lymph nodes (Supplementary Figure S1C). However,
both RNA interference or ectopic overexpression of
NSrp70 showed little effect on Jurkat T cells in terms of
their migration (chemokinesis) and activation (IL-2 ex-
pression) in response to SDF-1a and PMA+A23187, re-
spectively (Supplementary Figure S1D and E).
The absence of a connection between NSrp70 and T-cell
migration and activation led us to track the localization of
NSrp70 in various cell types, as a previous report
demonstrated that NSrp70 formed speckle structures in
the nucleus (15). We consistently observed typical
nuclear speckled patterns when green ﬂuorescent protein
(GFP)-tagged NSrp70 cDNA was transfected into COS-7
cells (Figure 1A). High-resolution confocal microscopic
analysis revealed either diffused or doughnut-shaped dis-
tribution of GFP-tagged NSrp70 in many cells
(Supplementary Figure S2A). However, a colocalization
study revealed that NSrp70 shows a precise overlap with
splicing factor SC35, conﬁrming its localization in nuclear
speckles (Supplementary Figure S2B). Endogenous
NSrp70 was also detected in the nucleus, but mostly in a
diffuse pattern in ﬁxed HEK293T cells (Figure 1B, left).
To clarify whether the slightly different pattern of GFP-
tagged NSrp70 compared to the endogenous NSrp70 in
terms of nuclear localization pattern is due to the artifact
of tagged protein, we further used Myc-tagged NSrp70
cDNA in 293T cells, and then co-localization study was
performed with SC35. myc-tagged NSrp70 also showed
similar pattern as endogenous NSrp70, ranging from the
diffuse pattern to the speckle pattern, and was unambigu-
ously overlapped with SC35, therefore suggesting that
tagged protein had little effect on NSrp70 localization.
Instead, it might be a difference resulted by the direct
visualization (GFP) versus indirect visualization after
antibody staining. Localization of NSrp70 was further
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HEK293T cells (Figure 1A and B, right). Sequence align-
ment of NSrp70 orthologs demonstrated a highly
conserved homology with other species (Supplementary
Figure S3).
NSrp70 is a novel SR-related protein and inﬂuences
alternative splice site selection
The speckle pattern of GFP_NSrp70 protein may corres-
pond to perichromatin ﬁbrils (PFs) and interchromatin
granule clusters (IGCs), which can be detected by
electron microscopy when cells are stained with antibodies
against components of the splicing machinery (18). To
further characterize the potential roles of NSrp70, we per-
formed alignment of full-length NSrp70 amino acids with
other speckle proteins according to the needle method of
EMBOSS Pairwise Alignment Algorithms. We also
searched the conserved domains in BLAST and Protein
Knowledgebase Database as described in ‘Materials and
Methods’ section. Through sequence analysis, however,
we found that NSrp70 has low-sequence similarity and
identity with classic SR proteins or SR-related proteins
(data not shown).
As we thought that the low percentage of similarity and
identity obtained through the needle method was due to
the whole-length sequence that has many inserted gaps, we
selected known RRM and RS domain sequences from dif-
ferent SR or SR-related protein, and then aligned them
with the total NSrp70 sequence according to the water
method of EMBOSS Pairwise Alignment Algorithms to
ﬁnd the best region of similarity between the two se-
quences. Interestingly, two N-terminal regions (20–85
and 170–289 amino acids) were observed to be in a
similar region as RRMs (Table 1). A signature sequence,
‘RDAEDA’, which appeared in known RRM sequences
of SR proteins, was also found between 20 and 85 amino
acids of NSrp70 (Supplementary Figure S3A). We also
found an RS-like region at the C terminus (290–551
amino acids), while its predicted RS-like region sequences
were interrupted by aspartic acid (D) or glutamic acid (E)
after arginine (R). To understand how far back in evolu-
tion does this protein go, we analyzed potential orthologs
proteins by ClustalW analysis. The constructed phylogen-
etic tree revealed that human NSrp70 shares 82%
sequence identity with bovine NSrp70, 14% identity
with human U2-associated, and 15% identity with SC35
(Supplementary Figure S3B). The analysis of orthologs
together with the fact that NSrp70 is a nuclear speckle
protein strongly suggests that NSrp70 is an SR-related
protein.
Figure 1. Exogenous and endogenous NSrp70 are localized within the nucleus as speckles or small punctuate forms. (A, left): COS-7 cells were
transfected for 24h with 2mg of pEGFP or pEGFP/NSrp70 cDNAs. The cells were stained with DAPI (blue) and phalloidin-TRITC (red), and were
observed under a confocal microscope equipped with a 100  objective. (B) Endogenous NSrp70 (green) was detected with a rabbit polyclonal
anti-NSrp70 antibody and visualized with an FITC-conjugated anti-rabbit antibody in HEK293T cells. (A and B) The subcellular localization of
NSrp70 was conﬁrmed by nuclear fractionation assay of the COS-7 (A, right) and HEK293T (B, right) cell lines. I-kB and PARP (or SC35) were
used as cytosolic and nucleoplasmic fraction markers.
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with other SR or SR-related proteins, we next conducted
in vivo splicing assays using minigenes to test whether
NSrp70 behaves like a typical SR protein i.e. whether it
can activate pre-mRNA splicing or regulate alternative
splicing in a concentration-dependent manner (5,19). To
this end, Tra2b1 or CD44 minigene was transfected into
HEK293T cells with increasing amounts of pEGFP/
NSrp70. RT–PCR was performed with primers directed
at sequences located in the ﬂanking constitutive exons.
As shown in Figure 2A, we found that addition of
NSrp70 in small increment from 0.5 to 2mg resulted in
an increased exon v2 exclusion from 69 to 92% in
Tra2b1 minigene and exon v5 inclusion from 39 to 65%
in CD44 minigene. As a control, cotransfection of Tra2b1
or CD44 with an empty vector, pEGFP-C1, did not
change the splicing pattern, demonstrating that the
splicing reaction and involvement of NSrp70 in splicing
modulation were not an artifact. Western blot data repre-
sent the protein amounts after transfection of GFP and
GFP_NSrp70 in HEK293T cells (Figure 2A).
To further conﬁrm that NSrp70 is indeed engaged in
alternative splicing modulation, we utilized another
splicing reporter minigene, Fas, to test the efﬁciency of
NSrp70 in an in vivo splicing assay. As shown in
Figure 2B, NSrp70 transfection caused  3–7-fold
increase in exon v6 inclusion of Fas minigene in both
HEK293T and Jurkat T cells. Importantly, we also
tested whether depletion of NSrp70 could oppositely
affect exon v6 inclusion of endogenous Fas in Jurkat T
cells. To obtain Jurkat T cells with stable depletion of
NSrp70, we utilized a lentiviral system that contains
shRNA targeted for NSrp70. As shown in Figure 2C, de-
pletion of NSrp70 resulted in increased exon v6 exclusion
of endogenous Fas. Taken together, these results strongly
demonstrate that NSrp70 can inﬂuence the alternative
splice site selection of various pre-mRNAs, including
Tra2b1, CD44 and Fas.
An important issue raised at this point was whether
NSrp70 directly interacts with the RNAs used in the
study. To this end, transfected or endogenous NSrp70
was immunoprecipitated with antibodies against myc
Table 1. Identiﬁcation of RRMs and RS-like region in NSrp70 and their percent similarity/identity as compared to other SR or SR-related
proteins
Protein name RRM
a RS domain Conserved regions in NSrp70
Region Similarity/Identity (%) Region Similarity/identity (%) RRM RS-like
Classical SR proteins
SRp75 2–72 43.2/ 29.5 179–494 39.9/23.6 233–292 282–552
104–163 40.9/20.5 335–370
SRp55 1–72 45.5/25 184–343 37.1/20.5 233–274 282–491
110–183 43/19 199–274
SC35 14–92 35.9/21.8 117–221 43.5/23.5 192–269 335–419
SRp40 4–74 37.3/24.1 182–267 51.1/22.7 188–264 445–531
108–181 30.9/18.6 178–274
9G8 11–84 30.9/18.6 121–238 38.3/24.1 178–274 281–410
Additional SR proteins
SRrp86 66–142 66.7/55.6 194–261 26.6/536 256–264 320–398
346–430 29.4/50.6 259–342
U1-70K 103–181 43.1/27.6 230–305 33.3/54.8 285–339 363–455
348–390 34.8/58.7 363–408
p54 33–113 35.8/17 247–353 26.8/44.7 39–88 281–376
XE7 147–256 33.8/25 642–691 52.8/34 502–554 303–352
SRp46 14–92 55/40 83–205 32.5/38.8 303–319 281–359
hTra2b 118–196 57.1/10.7 31–113 45.7/34.6 58–85 277–355
231–287 41.5/20.8 294–346
hTra2a 119–197 45.8/41.7 30–112 45.7/33 448–471 262–355
226–282 40.4/28.8 312–358
U2AF65 149–231 61.1/27.8 27–62 57.1/37.1 61–78 364–398
259–337 75/62 149–159
385–466 45.5/21.8 34–80
RNA binding SR-related factors
U2-associated protein SR140 274–355 40/28.3 922–1001 38.9/27.4 127–182 281–374
RBM23 166–243 58.8/47.1 366–382
263–341 43.9/26.8 470–502
RBM39 153–230 58.8/47.1 41–90 46.3/29.9 366–382 371–437
250–328 46.4/35.7 36–57
445–508 43.3/25 173–228
RBM5 98–178 48.6/28.3 206–235
231–315 62.5/37.5 473–488
SFRS15 508–582 46.2/40.8 501–550
aRRM and RS domain sequences of each SR and SR-related protein were collected from The Nuclear Protein Database and Protein Knowledgebase
UniPortKB, and then each sequence was aligned with NSrp70 full-length sequence by using water method of EMBOSS Pairwise Alignment
Algorithms to ﬁnd the best region of similarity between two sequences. The URLs used in this study was described in Supplementary Data.
Nucleic Acids Research, 2011,Vol.39, No. 10 4305(Figure 2D) or NSrp70 (Figure 2E), and then the precipi-
tates were analyzed for the presence of each minigene by
RT–PCR. All three minigenes were immunoprecipitated
by myc-tagged NSrp70 or endogenous NSrp70, suggesting
that NSrp70 physically interacts with RNAs, including
Tra2b1, CD44 and Fas.
Nuclear localization is required for NSrp70-mediated
alternative splicing
The RS domain of SR or SR-related proteins is thought to
be required for protein–protein interaction with each
other or with other components of the splicing
machineries (5,7,20) as well as for subcellular localization
(21,22). As we found an RS-like region in NSrp70, which
resembles the RS domain in other SR proteins, we
hypothesized that this region may contain the NLS
sequence. To this end, we generated a series of GFP-
tagged deletion mutants for probing NLS sequence in
the putative RS-like region of NSrp70. After transient
transfection, the localization of GFP-tagged NSrp70
mutants was analyzed by confocal microscopy. To better
monitor the localization, the ﬁxed cells were also counter
stained with endogenous SC35. In contrast to the wild-
type (GFP_NSrp70), deletion of amino acids spanning
the 439–558 (M1) region appeared to be localized in the
cytosol, suggesting that this region included the NLS
sequence (Figure 3A). To ﬁnd the exact NLS sequence,
Figure 2. NSrp70 inﬂuences alternative splice site selection of several minigenes in different cell types. (A) Promotion of exon v2 exclusion on Tra2b1
and exon v5 inclusion on CD44 minigene by NSrp70. HEK293T cells were cotransfected with increasing amounts of pEGFP/NSrp70 (0–2mg) and
2mg of the minigene. Parental vector (0–2mg) was added to ensure that similar amounts of cDNAs were transfected. Exon inclusion or exclusion was
determined by RT–PCR (top), as described in ‘Materials and Methods’ section. The ratio of exclusion or inclusion of Tra2b1 or CD44 minigene was
shown as a histogram (middle). Dose-dependent expression of GFP_NSrp70 and GFP was conﬁrmed by western blotting (bottom). (B) NSrp70
promotes exon v6 inclusion on Fas minigene in HEK293T or Jurkat T cells. Two micrograms of Fas minigene was transfected with 2mg of pEGFP/
NSrp70 or pEGFP into HEK293T or Jurkat T cells. Exon inclusion or exclusion was determined by RT–PCR. Note: P, parent; EV, pEGFP vector;
NSrp70, pEGFP/NSrp70. Asterisks denote an uncharacterized PCR product (A and B). (C) Interference of NSrp70 by shRNA decreases exon v6
inclusion in Jurkat T cells. psiLv-H1/scramble or psiLV-H1/shNSrp70 (CCDC55) vector was infected to Jurkat T cells by the lentiviral system. Exon
inclusion or exclusion was determined by RT–PCR. Note: M, 100bp DNA marker; SR, psiLv-H1/scramble, NSrp70, psiLV-H1/shNSrp70 infection.
The ratio of exon inclusion or exclusion splicing forms was analyzed by ImageJ. Each experiment was repeated at least three times to conﬁrm the
reproducibility of data. (D and E) mRNA of minigenes interacts to NSrp70. HEK293T cells were transfected with (D) or without (E) plasmid
expressing myc_NSrp70 and indicated minigene and then immunoprecipitated with anti-Myc (D) or anti-NSrp70 antibody (E). The RNAs in the
immunoprecipitates were then analyzed by RT–PCR using primers speciﬁc for the CD44, Fas or Tra2b1 transcripts of minigenes. Ten microliter of
the supernatant of total lysate was used for total input sample.
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(Figure 3B). Interestingly, we found that mutant M10
(531–540) localized in the cytosol, suggesting that this
region belongs to the NLS sequence of NSrp70. Further
point mutations at 536R/A or 537D/A demonstrated
that these two amino acids are critical residues for
nuclear localization and target the speckle compartment
(Figure 3C). To extend these ﬁndings with regard to the
functional role, we performed in vivo splicing assay with
Tra2b1 minigene. M1 (439–558), M8 (531–558) and
M10 (531–540), which localize in the cytosol, did not
induce alternative splicing (Figure 3D). Interestingly,
however, M7 (541–558), which localizes in the nucleus,
affected the alternative splice site selection and is compar-
able to that of the wild-type (Figure 3D). These results
demonstrate that nuclear localization by the NLS
sequence (531–540), including
536RD
537, is important for
the functional role of NSrp70. Further, we found that
this sequence does not match the known NLS sequence,
suggesting that this is a novel NLS sequence.
Coiled-coil domain of the N-terminus is critical for
alternative splicing activity
SR proteins contain one or two RRMs containing the
signature sequences RDAEDA, RDADDA and
SWQDLKD (23,24). Splice-site selection is determined
by the nature of the RRM (25). As NSrp70 also
contains the highly conserved RDAEDA sequence
between amino acids 47 and 70 at the N terminus
(Supplementary Figure S3), we investigated the role of
this sequence in terms of alternative splicing activity. As
the N terminus also contains a coiled-coil domain in
amino acids 106–161, we also tested whether this region
corresponds to the splicing activity of NSrp70. To this
end, we designed a series of N-terminal deletion constructs
and investigated their splicing activities for Tra2b1
minigene in HEK293T cells (Figure 4A). Interestingly,
although all of the deletion mutants (M11–M13) showed
nuclear speckle localization, M12 (1–170), a deletion
mutant of the coiled-coil domain, but not M11
(1–105), completely lost alternative splice site selection
of pre-mRNA of Tra2b1 (Figure 4B), suggesting that the
coiled-coil domain (106–170 amino acids) is critical for
alternative splicing activity of NSrp70. All expressed
proteins accumulated to similar levels in transfected
HEK293T cells, as veriﬁed by western blot analysis of
whole cell lysates (Figure 4B, right).
NSrp70 interacts with SC35 and ASF/SF2 through the
C-terminal RS-like region
As we found that NSrp70 colocalized with SC35, a
spliceosomal component (Supplementary Figure S2B),
we extended the experiment to test whether NSrp70 is
colocalized with other spliceosomal proteins such as
ASF/SF2 or non-spliceosomal proteins such as
acetylated-histone3, PML3, Sp100 and Daxx. We found
that NSrp70 was signiﬁcantly overlapped with SC35 and
ASF/SF2 but not with acetylated-histone3, PML3, Sp100
and Daxx, strongly suggesting that NSrp70 is a new
spliceosomal protein (Figure 5A). To prove the physical
interactions between NSrp70 and ASF/SF2 or SC35, we
generated Myc-tagged NSrp70 and GFP-tagged ASF/SF2
or SC35 and then cotransfected them into HEK293T cells.
As shown in Figure 5B (left), immunoprecipitation results
revealed that NSrp70 could interact with both ASF/SF2
and SC35 but not with PML3. To test whether native
proteins are also physically interacted, endogenous
NSrp70 was immunoprecipitated with anti-NSrp70
antibody, and then immunoblotted with anti-ASF/SF2
or anti-SC35 antibodies. As shown in Figure 5B (right),
endogenous NSrp70 were also physically interacted with
native forms of ASF/SF2 and SC35.
We next questioned whether the physical interaction
between NSrp70 and SC35 or ASF/SF2 is connected for
the splicing activity of NSrp70. As shown in Figure 5C
and D, although mutants M12 and M13 had no alterna-
tive splicing activity (Figure 4A and B), they could still
interact with SC35 or ASF/SF2, demonstrating that the
physical interaction of NSrp70 with these two
spliceosomal proteins is not directly connected with its
activity and further suggests that the C-terminal RS-like
region may include the interaction site. In fact, the RS
domain is known as a region that mediates protein–
protein interactions. For example, upon deletion of its
RS domain, SC35 fails to associate with Tra, Tra2 and
other SR proteins (7). In accordance with the previous
report, we found that upon partial deletion of the
RS-like region (290–471) in NSrp70, the protein failed
to interact with ASF/SF2 or SC35 (Figure 5E).
Speckle localization through the RS-like region is also
important for NSrp70-mediated splicing activity
Our results thus far demonstrated the requirement for
both the N-terminal coiled-coil domain and C-terminal
NLS for proper activity of NSrp70, but did not establish
the function of the RS-like region through which SC35
and ASF/SF2 are associated. We therefore examined
whether the RS-like region is also involved in NSrp70-
mediated splicing function. Interestingly, we found that
partial deletion of this region (M15; 290–471) caused
the protein to completely lose its localization in the
nuclear speckles and revealed its diffuse pattern in
the nucleus, demonstrating that this region contained the
sequence for both speckle localization (Figure 6A) and
SC35 and ASF/SF2 association (Figure 5E). To further
conﬁrm whether the N-terminal region alone is enough to
induce splicing activity, the RS-like region was replaced
with the foreign sequence containing an 18 amino acid
NLS sequence taken from NUCKS (26). Figure 6A
shows a schematic map of mutants and their nuclear lo-
calization. Interestingly, all mutants showed a similar
pattern as M15, suggesting that the RS-like region is im-
portant for speckle localization. Consequently, these
mutants showed no activity for Tra2b1 exon v2 exclusion
in HEK293T cells (Figure 6B). Taken together, although
we did not further determine the exact sequence for
speckle localization, the region for SC35 and ASF/SF2
association might be overlapping with that for speckle
localization. Therefore, our current result suggests that
Nucleic Acids Research, 2011,Vol.39, No. 10 4307Figure 3. Nuclear localization is mediated by a novel NLS sequence and is required for NSrp70-mediated alternative splicing. (A–C) Schematic
diagram of deletion or substitution mutants of NSrp70 (left) and their subcellular localization in HEK293T cells (right). HEK293T cells were
transfected with pEGFP vectors (1mg) that contain wild-type or mutant NSrp70. After 24h of transfection, cells were ﬁxed, stained with anti-SC35
antibody followed by TRITC-conjugated anti-mouse antibody, and visualized by confocal microscopy (right). Sequence alignment of the NLS
(continued)
4308 Nucleic Acids Research, 2011,Vol.39, No. 10speckle localization is important for the functional role of
NSrp70.
NSrp70 has a recessive phenotype and knockout of
NSrp70 leads to early embryonic lethality
Because human NSrp70 has high similarity (75.6%) with
its mouse ortholog, as depicted in Supplementary
Figure S3, we investigated the role of NSrp70 in a
mouse system generated in a large-scale Gene-Trap
project (27). By sequence analysis of DNA isolated from
NSrp70
+/GT (Gene-Trap) heterozygous mice, we conﬁrmed
that the retroviral Gene-Trap vector was inserted in
intron 1 of the mouse NSrp70 gene on chromosome 11,
downstream of the exon encoding the initiation methio-
nine (Figure 7A). To generate NSrp70
GT/GT mice, hetero-
zygous mutant mice were intercrossed and the genotypes
of the offspring were analyzed by PCR. Among more than
95 offspring investigated, only NSrp70
+/GT ( 80%) and
NSrp70
+/+ ( 20%) mice, but not viable NSrp70
GT/GT
mice, were detected (Fig. 7B), leading to the assumption
that knockout of NSrp70 in vivo results in embryonic le-
thality. To determine in which developmental stage
knockout of NSrp70 induces lethality, we carried out
genotyping of embryos from embryonic day (E) 6.5 to
19.5. However, no homozygous embryo was observed
(data not shown), suggesting that homozygous mutation
leads to embryonic lethality shortly after implantation.
In contrast, heterozygous mice (NSrp70
+/GT) showed no
differences to wild-type (NSrp70
+/+) with regard to body
weight and expression levels of NSrp70 protein (Figure 7C
and D). In addition, no differences were observed in terms
of IL-2 response in splenocytes, as evaluated by mitogen
stimulation and migration of isolated T cells by SDF-1a
(Figure 7E and F), suggesting that NSrp70 has a recessive
phenotype in mice.
Figure 3. Continued
sequence with other species, as analyzed by Clustal X and GeneDoc, is depicted in (C) (left bottom). (D) Nuclear localization is required for
NSrp70-mediated exon 2 exclusion of Tra2b1 minigene. HEK293T cells were cotransfected with Tra2b1 minigene (2mg) and the indicated NSrp70
constructs (2mg). After 24h of transfection, exon v2 exclusion was determined by RT–PCR (left). The ratio of exclusion or inclusion of Tra2b1
or CD44 minigene was shown as a histogram (left bottom). GAPDH and b-actin are shown as loading controls. The protein levels of GFP
and GFP_NSrp70 mutants were conﬁrmed by western blotting (bottom). Experiment was repeated at least three times to conﬁrm the reproducibility
of data.
Figure 4. Deletion of the coiled-coil domain results in loss of alternative splicing activity. (A) Schematic diagram of deletion mutants of NSrp70 (left)
and their subcellular localization with SC35 in HEK293T cells (right). (B) HEK293T cells were cotransfected with Tra2b1 minigene (2mg) and the
indicated NSrp70 constructs (2mg). After 24h of transfection, exon v2 exclusion was determined by RT–PCR (left). The ratio of exclusion or
inclusion of Tra2b1 or CD44 minigene was shown as a histogram (left bottom). GAPDH and b-actin are shown as loading controls. The protein
levels of GFP and GFP_NSrp70 mutants were conﬁrmed by western blotting (bottom). Experiment was repeated at least three times to conﬁrm the
reproducibility of data.
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We report here the identiﬁcation and characterization of a
novel SR-related and nuclear speckle protein NSrp70
whose expression is high in the testis, kidney and
immune tissues such as spleen and lymph nodes.
Endogenous NSrp70 protein contained novel sequences
for NLS and speckle localization and was found to be
colocalized with SC35 and ASF/SF2 in nuclear speckles.
In addition, NSrp70 had a putative RRM in the N
terminus followed by an RS-like region in the C
terminus, suggesting that NSrp70 is a novel SR-related
protein that may be involved in pathways related to
RNA processing. Accordingly, functional splicing assay
for NSrp70 with reporter minigenes demonstrated that
NSrp70 could modulate alternative splice site selection
in vivo. Particularly, the fact that NSrp70 knockout mice
produced no progeny strongly suggests that NSrp70 is an
essential gene in early embryonic development.
Alternative splicing is considered to be the most import-
ant source of protein diversity in vertebrates (28,29). To
date, hundreds of splicing factors have been identiﬁed
(30); however, attempts to explain genome-wide alterna-
tive splicing patterns will be impossible without a
complete list of alternative splicing regulators. Although
we unexpectedly found NSrp70 in rapidly migrating T
cells, our results unambiguously demonstrated that
NSrp70 is a novel protein localized in nuclear speckles
that functions as a splicing regulator. This ﬁnding was
substantiated by the fact that NSrp70 was detected as an
uncharacterized protein in the nucleus by the systemic
approach that aimed to deﬁne the subcellular localization
of novel proteins identiﬁed by large-scale cDNA
sequencing (15).
Many nuclear factors show a punctuate staining pattern
when observed by indirect immunoﬂuorescence micros-
copy, and are localized in distinct structures, such as
speckles, paraspeckles, nucleoli, cajal bodies, GEMS and
Figure 5. NSrp70 interacts with ASF/SF2 and SC35 through the RS-like region of NSrp70. (A) HEK293T cells were cotransfected with pEGFP/
NSrp70, pmCherry/NSrp70, pmCherry/SC35, pEGFP/ASF/SF2, pEGFP/PML3, pEGFP/SP100 or pEGFP/Daxx. Each transfectant was visualized
in the live chamber by using a confocal microscope equipped with a 100  objective. For staining of the endogenous acetylated histone (Act-His),
pEGFP/NSrp70-transfected cells were cultured on an 18-mm cover glass for 24h, and then stained with rabbit polyconal anti-human acetyl-histone
H2A (Lys5) antibody followed by TRITC-conjugated anti-rabbit antibody. (B) Coimmunoprecipitation of NSrp70 with ASF/SF2 or SC35. Left:
HEK293T cells were transfected with pCS4-3Myc/NSrp70 and the indicated constructs, and then the cell extracts (1mg) were immunoprecipitated
with 50ml of anti-GFP antibody-conjugated Sepharose 4B slush. Immune complexes were resolved on an SDS–PAGE gel and blotted. The presence
of NSrp70 was determined by using an anti-Myc antibody. The expression of indicated constructs was shown by western blotting. Right: HEK293T
cells were immunoprecipitated with anti-NSrp70 antibody-conjugated Sepharose 4B slush. Immune complexes were resolved as described above and
blotted with an anti-ASF/SF2 or SC35 antibodies. (C–E) HEK293T cells were transfected with pCS4-3Myc/SC35 or pCS4-3Myc/ASF/SF2 and the
indicated mutant constructs of NSrp70 (M11, M12, M13, or M15). Immunoprecipitation was performed as described above.
4310 Nucleic Acids Research, 2011,Vol.39, No. 10PML bodies (31). The obvious interaction of NSrp70 with
speckle proteins such as ASF/SF2 or SC35, but not with
PML bodies such as PML3, Daxx or SP100, demonstrates
that NSrp70 is strictly located in speckles. As many
pre-mRNA splicing factors are enriched in nuclear
speckle, it is natural to question whether NSrp70 is a
member of the SR protein or SR-related protein family
(4). The following two factors are considered. First, SR
proteins are characterized by the presence of RRM and
the SR domain, which consists largely of serine/arginine
repeats (4). The RRM has a consensus sequence of  90
amino acidscontaining a central sequence of eight or
six conserved residues that are mainly aromatic and posi-
tively charged (32–34). SR proteins also contain signa-
ture sequences such as RDAEDA, RDADDA and
SWQDLKD (23,24). Second, SR proteins contain the
RS domain at the C terminus after one or two copies of
RRM at the N terminus. However, the fact that the ﬁrst
homology search based on the conserved domain of the
proteins resulted in no obvious RRM, while a
second-round alignment with the selected RRM sequences
from the known SR or SR-related proteins found putative
RRM sites at two regions in the N terminus (20–85 and
161–290 amino acids), suggests that NSrp70 is not a
typical member of SR proteins.
No clear RS domain that is conserved in other SR
proteins was found in NSrp70. However, the sequences
that cover the 290–551 amino acids region revealed con-
secutive RS, SR, RD and RE repeats, thereby representing
an RS-like region in NSrp70. It is becoming increasingly
clear that the RS domain mediates protein–protein inter-
actions and, in some cases, acts as NLS (9,21,22). In an
agreement with this observation, we found that the
RS-like region in NSrp70 could not only bind to ASF/
SF2 or SC35 but also contains an NLS sequence.
Furthermore, the RS-like region might contain active
sites of NSrp70 as it has been reported that replacement
of the RS residue in ASF/SF2 to RD/RE, but not RG,
could induce splicing of pre-mRNA in vitro (35,36). The
RS-like region also affects nuclear speckle formation
because partial deletion of this region (290–471 amino
acids) disabled the formation of the nuclear speckle.
Collectively, the presence of RRM and the RS-like
region containing NLS and nuclear speckle sequences
strongly suggest that NSrp70 is an SR-related protein.
Based on the prediction by UniProtKB/Swiss-Prot,
we identiﬁed two potential coiled-coil domains at the
regions spanning 106–170 and 379–438 amino acids. The
ﬁrst region might be critical for the splicing activity as
deletion of this region (106–170 amino acids) led to
Figure 6. Speckle localization through the RD/RE-rich domain is important in NSrp70-mediated alternative splicing. (A) Schematic diagram of deletion
mutants of NSrp70 (left). HEK293T cells were transfected with the indicated construct (1mg). After 24h of transfection, cells were visualized in the live
chamber by using a confocal microscope equipped with a 100  objective. (B) HEK293T cells were cotransfected with Tra2b1 minigene (2mg) and the
indicated construct (1mg). After 24h of transfection, exon v2 exclusion was determined by RT–PCR (left top). The ratio of exclusion of Tra2b1 minigene
was shown as a histogram (left bottom). GAPDH and b-actin are shown as loading controls. The protein levels of GFP and GFP_NSrp70 mutants were
conﬁrmed by western blotting (bottom). Experiment was repeated at least three times to conﬁrm the reproducibility of data.
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the protein. As the coiled-coil region can mediate homo-
or heterodimeric interaction, we determined whether
this region is the site for binding to ASF/SF2 and
SC35 or, otherwise, mediates self-interaction (i.e.
homodimerization). However, the result that NSrp70 still
binds to either ASF/SF2 or SC35 upon deletion of 1–129
amino acids (M13: 1–129) suggests that this site does not
have a role in the interaction with other splicing regulators.
Although further studies are needed to verify its role(s), we
recently obtained evidence that this site is required for
homodimeric interaction (data not shown). There is also
another possibility that this coiled-coil domain can
function as an RRM. For example, it has been reported
that RNG105, a novel RNA-binding protein in neuronal
RNA granules, directly binds to the mRNA through its
coiled-coil domain (37). However, as this site is predicted
to be located between two potential RRMs in the
N terminus, it is also plausible that this site can stabilize
RNA binding mediated by two RRMs, presumably
through homodimeric interaction. Therefore, further
studies are now under way to identify the relationship
between the coiled-coil domain and two RRMs in NSrp70.
The interaction of NSrp70 with SC35 and/or ASF/SF2
through the RS-like region led us to investigate whether
NSrp70 could affect the function of SC35 or ASF/SF2.
However, we did not see any difference in terms of alter-
native splicing activity and speckle localization when
NSrp70 expression was down-regulated by siRNA (data
not shown). Functional redundancy could be one of the
possible reasons. For example, ASF/SF2 and SC35 were
shown to be functionally interchangeable in in vitro
splicing assays; both activate constitutive splicing in SR
protein-depleted extracts (also called S100 extracts) and
induce the same splice site selection in alternatively
spliceable model pre-mRNAs (38). It is also possible
that NSrp70 is not a major protein that is involved in
mRNA splicing. However, the lack of progeny of
NSrp70 knockout mouse suggests that this protein is es-
sential for development, although the exact mechanism
behind embryonic lethality due to NSrp70 knockout is
not currently deﬁned. Since we did not see any embryo
that shows a homozygotic genotype, we believe that this
gene is involved in very early stages of embryonic devel-
opment. Therefore, we need to examine the effect of
NSrp70 in early stages, including blastocyst and morula.
Figure 7. NSrp70-deﬁcient homozygous mouse exhibits early embryonic lethality. (A) Schematic diagram of the exchangeable Gene-Trap system.
Note: numbered boxes, exons; lines, introns; diagonal lines, regions of homology where crossover can take place; b-geo, encoding a fusion protein
with both b-galactosidase and neomycin phosphotransferase activity; SA, splicing acceptor; pA, polyadenine. Representative gel data revealed the
PCR products of NSrp70
+/+ and NSrp70
+/GT. Primers used target the region from EX1 to EX2 (1736bp) and the trap vector (605bp), respectively.
(B) Intercrossing the heterozygous mouse (NSrp70
+/GT) produced no offspring homozygous for the allele containing the Gene-Trap vector (GT). The
bar graph represents the number of offspring litters from the intercrossed NSrp70
+/GT mice. (C) Body weight changes in NSrp70
+/+ and NSrp70
+/GT
mice. Mice were weighed every week through the entire experimental period indicated. Data represent mean±SEM (n=8). (D) Western blot
analysis was performed using rabbit polyclonal anti-NSrp70 antibody with mouse tissues from NSrp70
+/+ and NSrp70
+/GT (50mg for each lane).
mGAPDH was used as a loading control. (E) Lymphocytes from NSrp70
+/+ and NSrp70
+/GT mouse were stimulated with PMA (200nM) and
A23187 (1mM) for 24h, and then the expression of mIL-2 and mNSrp70 mRNA was determined by RT–PCR. mGAPDH was used as a loading
control. (F) Lymphocytes (5 10
5) from NSrp70
+/+ or NSrp70
+/GT mice were allowed to migrate to the SDF-a (50ng/ml)-containing lower well for
2.5h at 37 C. The bar graph represents quantitative determinations of migrated cells obtained from three different ﬁelds of lower compartment.
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factor belonging to the highly conserved family of SR
proteins, is essential for early embryonic development,
and that mutant preimplantation embryos fails to form
blastocytes and died at the morula stage (39). Knockout
of some individual SR genes in mice is also known to
result in early embryonic lethality (10,12,39). Taken
together, these in vivo results suggest that SR proteins
have their own distinctive role in vivo rather than a mere
functional redundancy. Identiﬁcation of distinct DNA se-
quences in alternatively spliced exons that are responsive
to speciﬁc SR proteins also reveals the importance of each
SR protein among redundant SR proteins in vivo (40).
We have initially identiﬁed NSrp70 gene by microarray
as a candidate gene that may affect T-cell migration. We
conﬁrmed that NSrp70 is highly expressed in motile
Jurkat T cells compared to non-motile Jurkat T cells
(Supplementary Figure S1A). In addition, in silico
analysis based on BioGPS demonstrated that NSrp70
was highly expressed in some immune-related cells, and
this result was supported by Northern blot analysis
(Supplementary Figure S1B and C). Nevertheless,
overexpression or knockdown of NSrp70 did not show
any effect in terms of chemokinesis by hSDF-1a and
T-cell activation by PMA and A23187 (Supplementary
Figure S1D and E). Interestingly, however, a recent
report demonstrated that this gene is 2.4-fold highly ex-
pressed in two invasive and metastatic subpopulations of
tumor cells isolated from two different mammary tumor
types (PyMT and MTLn3) (data are available at the Cell
Migration Gateway consortium website; http://cmckb
.cellmigration.org). More interestingly, according to the
WormBase database (http://www.wormbase.org/), there
were variations in the migration pattern of distal tip
cells compared to control animals when NSrp70 expres-
sion was disrupted by RNAi. These ﬁndings support the
idea that NSrp70 could still be involved in cell migration.
Further studies are needed to verify the role of NSrp70 in
immune cell migration.
In conclusion, we identiﬁed a novel protein, NSrp70,
with structural features similar to certain SR-related
proteins, and characterized its subcellular localization in
nuclear speckles. We further delineated its function with
regard to modulation of pre-mRNA alternative splicing
in vivo based on its subnuclear speckled distribution
pattern and physical interaction with SC35 and ASF/
SF2. In addition, we showed that this protein is essential
for early embryonic development. Further study, in
addition to the current results, of this novel splicing regu-
lator may provide us with new information on RNA
biogenesis.
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